Brain Cancers and Tumor Information
Brain Cancer & Tumor Treatment
Cyberknife Stereotactic Radiosurgery For Brain Cancer
Acoustic Neuroma Patient Video
Cyberknife Radiosurgery for Brain Cancer
The CyberKnife® Radiosurgery System was cleared by the U.S. Food and Drug Administration in 1999 to treat tumors in the head and base of the skull. Despite its name, the CyberKnife Radiosurgery is not a surgical procedure. In fact, Cyberknife treatment is completely non-invasive. The CyberKnife System delivers high doses of radiation directly to brain tumors. The CyberKnife Stereotactic Radiosurgery System can be used for brain tumors that are considered inoperable because of their location in the head, for those patients who cannot undergo brain cancer surgery due to their poor medical condition, or who refuse surgery. CyberKnife can treat benign, or non-cancerous, tumors and other conditions, such as trigeminal neuralgia and arterial venous malformations (AVMs). Cyberknife targets brain cancers and tumors without a bulky headframe and delivers pinpont radiation.
CyberKnife brain cancer treatments are typically performed on an outpatient basis over a period of one to five days, requiring no overnight hospital stays. Cyberknife patients experience minimal to no side effects with a quick recovery time.